BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1694389)

  • 1. The immunohistochemical profile of malignant mixed müllerian tumor. Overlap with endometrial adenocarcinoma.
    Meis JM; Lawrence WD
    Am J Clin Pathol; 1990 Jul; 94(1):1-7. PubMed ID: 1694389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34 immunohistochemistry in female genital tract carcinosarcoma (malignant mixed müllerian tumors) supports a dominant role of the carcinomatous component.
    Costa MJ; Guinee D
    Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):293-9. PubMed ID: 11127921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma (malignant mixed müllerian [mesodermal] tumor) of the uterus and ovary. Correlation of clinical, pathologic, and immunohistochemical features in 29 cases.
    Costa MJ; Khan R; Judd R
    Arch Pathol Lab Med; 1991 Jun; 115(6):583-90. PubMed ID: 1710102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mixed Müllerian tumors of the uterus. An immunohistochemical study.
    Auerbach HE; LiVolsi VA; Merino MJ
    Int J Gynecol Pathol; 1988; 7(2):123-30. PubMed ID: 3294195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine Carcinosarcomas: Clinical, Histopathologic and Immunohistochemical Characteristics.
    Chen X; Arend R; Hamele-Bena D; Tergas AI; Hawver M; Tong GX; Wright TC; Wright JD
    Int J Gynecol Pathol; 2017 Sep; 36(5):412-419. PubMed ID: 28700424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrauterine pelvic malignant mixed mesodermal tumors. A study of 10 cases with immunohistochemistry.
    Deligdisch L; Plaxe S; Cohen CJ
    Int J Gynecol Pathol; 1988; 7(4):361-72. PubMed ID: 2466009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of immunohistochemistry in distinguishing ovarian sertoli-stromal cell tumors from carcinosarcomas.
    Costa MJ; Morris RJ; Wilson R; Judd R
    Hum Pathol; 1992 Jul; 23(7):787-97. PubMed ID: 1612579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant mixed müllerian tumors. An ultrastructural and immunohistochemical analysis with histogenetic considerations.
    Geisinger KR; Dabbs DJ; Marshall RB
    Cancer; 1987 May; 59(10):1781-90. PubMed ID: 2435401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.
    Guarino M; Giordano F; Pallotti F; Polizzotti G; Tricomi P; Cristofori E
    Tumori; 1998; 84(3):391-7. PubMed ID: 9678624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WT1 immunoprofiling and comparison of malignant Mullerian mixed tumors of the female genital tract.
    Franko A; Magliocco AM; Duan Q; Duggan MA
    Int J Gynecol Pathol; 2010 Sep; 29(5):452-8. PubMed ID: 20736771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
    Mikami Y; Hata S; Kiyokawa T; Manabe T
    Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinosarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics.
    Kernochan LE; Garcia RL
    J Natl Compr Canc Netw; 2009 May; 7(5):550-6; quiz 557. PubMed ID: 19460280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eight cases of malignant mixed Müllerian tumor (carcinosarcoma) of the uterus: findings in SurePath™ cervical cytology.
    Gupta N; Dudding N; Smith JH
    Diagn Cytopathol; 2014 Feb; 42(2):165-9. PubMed ID: 22865798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
    Murray SK; Clement PB; Young RH
    Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of antibodies to intermediate filament proteins in simple and complex tumors of the female genital tract.
    Puts JJ; Moesker O; Aldeweireldt J; Vooijs GP; Ramaekers FC
    Int J Gynecol Pathol; 1987; 6(3):257-74. PubMed ID: 2828258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant mixed müllerian tumors: an immunohistochemical study of 47 cases, with histogenetic considerations and clinical correlation.
    George E; Manivel JC; Dehner LP; Wick MR
    Hum Pathol; 1991 Mar; 22(3):215-23. PubMed ID: 1706302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary malignant mixed Müllerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of the literature.
    Garamvoelgyi E; Guillou L; Gebhard S; Salmeron M; Seematter RJ; Hadji MH
    Cancer; 1994 Aug; 74(3):854-63. PubMed ID: 7518735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomatoid carcinomas of the female genital tract (malignant mixed mullerian tumors).
    Colombi RP
    Semin Diagn Pathol; 1993 May; 10(2):169-75. PubMed ID: 7690151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of various antigens by different components of uterine mixed müllerian tumors. An immunohistochemical study.
    Chung MT; Mukai K; Teshima S; Kishi K; Shimosato Y
    Acta Pathol Jpn; 1988 Jan; 38(1):35-45. PubMed ID: 2452553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mesonephric tumors of the female genital tract: a clinicopathologic study of 9 cases.
    Bagué S; Rodríguez IM; Prat J
    Am J Surg Pathol; 2004 May; 28(5):601-7. PubMed ID: 15105647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.